Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you.
Loratadine tablets contain the active substance loratadine which belongs to the class of medicines called 'antihistamines'.
Loratadine tablets help to reduce your allergy symptoms by stopping the effects of a substance called 'histamine', which is produced in the body when you are allergic to something.
Loratadine tablets relieve symptoms associated with allergic rhinitis (for example, hay fever) and perennial allergic rhinitis (year-round allergy symptoms). Symptoms include sneezing, runny nose, nasal itching, burning, itching and watering of the eyes.
They may also be used to help relieve symptoms of chronic idiopathic urticaria (itching and redness), often known as hives or nettle rash.
You must talk to a doctor if you do not feel better or if you feel worse after 7 days.
Do not take Loratadine Tablets if you:
Talk to your doctor, pharmacist or nurse before taking Loratadine tablets if:
Do not give Loratadine tablets to children younger than 6 years or weighing ≤ 30 kg. The safety and efficacy of Loratadine tablets have not been established in children under 2 years.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.
Loratadine tablets have not been shown to add to the effects of an alcoholic drink.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. As a precaution, avoid use during pregnancy. Do not take if you are breast-feeding as loratadine passes into breast milk.
At the recommended dose, Loratadine tablets are not expected to cause drowsiness or affect your ability to drive or use machines. However, very rarely some people experience drowsiness.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor, pharmacist or nurse has told you. Check with your doctor or pharmacist if you are not sure.
Recommended dose:
If symptoms persist or worsen after 7 days of treatment, see your doctor.
The tablet should be swallowed whole with a drink of water. It may be taken with or without food. Try to take it at the same time each day to help you remember.
Talk to your doctor or pharmacist straight away. No serious problems are expected; you may get a headache, rapid heartbeat or feel sleepy.
Take one as soon as you remember, then continue as before. Do not take a double dose to make up for a forgotten dose.
Ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most commonly reported in adults and children ≥ 12 years:
Most commonly reported in children 6-12 years:
Very rare side effects (may affect up to 1 in 10 000 people):
Frequency not known:
If you get any side effects, talk to your doctor or pharmacist. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
White to off-white, round, uncoated tablets debossed with "R" on one side and "10" on the other. Available in blister strips of 7, 10, 14, 20, 21, 30 or 100 tablets. Not all pack sizes may be marketed.
SUN PHARMA UK LIMITED
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, United Kingdom
Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
Alkaloida Chemical Company Zrt., 4440 Tiszavasvári, Kabay János u. 29, Hungary
This leaflet was last revised in November 2023.
Full name: Loratadine Flexpen 100 units/ml solution for injection in pre-filled pens
- Invented name part: Loratadine FlexPen
- Scientific name part: Insulin
- Strength part: 100 units/ml
- Pharmaceutical dose form part: solution for injection in pre-filled pens
Name usage: English (United Kingdom)
Authorised dose form:
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: active
Product classification: